Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Janssen-Cilag Pty Ltd
Scientific Title
A Randomized, Open-label Phase 3 Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Patients With EGFR Exon 20ins Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer